Molecular Devices and STEMCELL Technologies Team Up to Automate Organoid Research
Validated on the CellXpress.ai automated cell culture system, the new workflow combines organoid biology expertise and laboratory automation to help researchers reduce variability, expand scale, and move discoveries toward impact with more confidence. The post Molecular Devices and STEMCELL Technologies Team Up to Automate Organoid Research appeared first on GEN - Genetic Engineering and…
Molecular Devices and STEMCELL Technologies have joined forces to automate organoid research through a validated workflow compatible with STEMCELL's IntestiCult Plus medium. This collaboration enables researchers to efficiently culture, monitor, and analyze human intestinal organoids using the CellXpress.ai automated cell culture system.
The workflow aims to streamline organoid culture, reduce experimental variability, and scale human-relevant models for drug discovery, disease research, and translational biology. By combining STEMCELL's tissue-specific expertise and Molecular Devices' automation capabilities, the partnership removes barriers to implementing advanced cellular models, accelerating research workflows, and fostering reproducible results.
The collaboration plans to expand the portfolio of validated applications for various organoid models in drug discovery, disease modeling, toxicology, and translational research.
Written by urgent.news from GEN Biotechnology's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
